Sun Pharmaceutical Industries Limited
SUNPHARMA
Classificação em ações
#520
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Preço da ação
$19.24
Última sincronização: 2026-10-19
Valor de mercado
$46.15B
Variação (1 dia)
-0.97%
Variação (1 ano)
0.11%
País
IN
Negociar Sun Pharmaceutical Industries Limited (SUNPHARMA)
Categoria
Healthcare
Rácio P/S de Sun Pharmaceutical Industries Limited (SUNPHARMA)
Rácio P/S em October 2026 TTM: 7.06
De acordo com os relatórios financeiros mais recentes e o preço das ações da Sun Pharmaceutical Industries Limited, o rácio P/S atual (TTM) é 7.06. No final de 2024, o rácio P/S era 8.06.
Histórico do rácio P/S da Sun Pharmaceutical Industries Limited de 2004 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 7.06 | -8.81% |
| 2025 | 7.74 | -3.96% |
| 2024 | 8.06 | 49.97% |
| 2023 | 5.37 | -5.34% |
| 2022 | 5.68 | 32.61% |
| 2021 | 4.28 | 66.34% |
| 2020 | 2.57 | -34.88% |
| 2019 | 3.95 | -14.31% |
| 2018 | 4.61 | -12.68% |
| 2017 | 5.28 | -24.75% |
| 2016 | 7.02 | -21.91% |
| 2015 | 8.99 | 21.43% |
| 2014 | 7.40 | -0.77% |
| 2013 | 7.46 | 1.13% |
| 2012 | 7.38 | -7.90% |
| 2011 | 8.01 | -15.75% |
| 2010 | 9.51 | 76.44% |
| 2009 | 5.39 | -26.13% |
| 2008 | 7.29 | -21.66% |
| 2007 | 9.31 | -4.42% |
| 2006 | 9.74 | 34.88% |
| 2005 | 7.22 | 17.66% |
| 2004 | 6.14 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
